These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19551366)

  • 21. High-throughput screening of model bacteria.
    Zlitni S; Blanchard JE; Brown ED
    Methods Mol Biol; 2009; 486():13-27. PubMed ID: 19347613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statistical and graphical methods for quality control determination of high-throughput screening data.
    Gunter B; Brideau C; Pikounis B; Liaw A
    J Biomol Screen; 2003 Dec; 8(6):624-33. PubMed ID: 14711388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei.
    Mackey ZB; Baca AM; Mallari JP; Apsel B; Shelat A; Hansell EJ; Chiang PK; Wolff B; Guy KR; Williams J; McKerrow JH
    Chem Biol Drug Des; 2006 May; 67(5):355-63. PubMed ID: 16784460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Image-based chemical screening.
    Carpenter AE
    Nat Chem Biol; 2007 Aug; 3(8):461-5. PubMed ID: 17637778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simplified and high-throughput chromogenic assay for testing tissue factor-dependent procoagulant activity.
    Jiang W; Kou J; Yuan S; Sun L; Yu B
    J Biomol Screen; 2011 Mar; 16(3):295-302. PubMed ID: 21310849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-based and biochemical screening approaches for the discovery of novel HIV-1 inhibitors.
    Westby M; Nakayama GR; Butler SL; Blair WS
    Antiviral Res; 2005 Sep; 67(3):121-40. PubMed ID: 16112209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel high-throughput cellular screening assay for the discovery of HIV-1 integrase inhibitors.
    Van Loock M; Meersseman G; Van Acker K; Van Den Eynde C; Jochmans D; Van Schoubroeck B; Dams G; Heyndrickx L; Clayton RF
    J Virol Methods; 2012 Feb; 179(2):396-401. PubMed ID: 22172974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and implementation of high throughput screening assays.
    Macarrón R; Hertzberg RP
    Methods Mol Biol; 2002; 190():1-29. PubMed ID: 12029816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assay development and screening of human DGAT1 inhibitors with an LC/MS-based assay: application of mass spectrometry for large-scale primary screening.
    Zhang JH; Roddy TP; Ho PI; Horvath CR; Vickers C; Stout S; Hubbard B; Wang YK; Hill WA; Bojanic D
    J Biomol Screen; 2010 Jul; 15(6):695-702. PubMed ID: 20484097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiplexing nuclear receptors for agonist identification in a cell-based reporter gene high-throughput screen.
    Grover GS; Turner BA; Parker CN; Meier J; Lala DS; Lee PH
    J Biomol Screen; 2003 Jun; 8(3):239-46. PubMed ID: 12857377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An integrative biology approach for analysis of drug action in models of human vascular inflammation.
    Kunkel EJ; Dea M; Ebens A; Hytopoulos E; Melrose J; Nguyen D; Ota KS; Plavec I; Wang Y; Watson SR; Butcher EC; Berg EL
    FASEB J; 2004 Aug; 18(11):1279-81. PubMed ID: 15208272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in electrophysiology-based screening technology and the impact upon ion channel discovery research.
    Southan A; Clark G
    Methods Mol Biol; 2009; 565():187-208. PubMed ID: 19551363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of division-arrested cells for cell-based high-throughput screening and profiling.
    Digan ME; Pou C; Niu H; Zhang JH
    J Biomol Screen; 2005 Sep; 10(6):615-23. PubMed ID: 16103416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using computational techniques in fragment-based drug discovery.
    Desjarlais RL
    Methods Enzymol; 2011; 493():137-55. PubMed ID: 21371590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypothesis-driven screening.
    Schopfer U; Engeloch C; Höhn F; Mees H; Leeds J; Glickman F; Scheel G; Ferrand S; Fekkes P; Pfeifer M
    Methods Mol Biol; 2009; 575():297-316. PubMed ID: 19727621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
    Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
    Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A high-throughput drug screen targeted to the 5'untranslated region of Alzheimer amyloid precursor protein mRNA.
    Bandyopadhyay S; Ni J; Ruggiero A; Walshe K; Rogers MS; Chattopadhyay N; Glicksman MA; Rogers JT
    J Biomol Screen; 2006 Aug; 11(5):469-80. PubMed ID: 16928984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case studies of minimizing nonspecific inhibitors in HTS campaigns that use assay-ready plates.
    Liu Y; Beresini MH; Johnson A; Mintzer R; Shah K; Clark K; Schmidt S; Lewis C; Liimatta M; Elliott LO; Gustafson A; Heise CE
    J Biomol Screen; 2012 Feb; 17(2):225-36. PubMed ID: 21940710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Building predictive models for mechanism-of-action classification from phenotypic assay data sets.
    Berg EL; Yang J; Polokoff MA
    J Biomol Screen; 2013 Dec; 18(10):1260-9. PubMed ID: 24088371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An overview of drug screening using primary and embryonic stem cells.
    Eglen RM; Gilchrist A; Reisine T
    Comb Chem High Throughput Screen; 2008 Aug; 11(7):566-72. PubMed ID: 18694393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.